Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Profit before tax | 124.33 | 52.73 | 56.01 | 16.65 | 11.95 |
| Net cashflow-operating activity | 107.07 | 118.01 | 19.81 | 15.63 | -13.62 |
| Net cash used in investing activity | 8.82 | -24.10 | -20.20 | -7.55 | -7.69 |
| Netcash used in fin. activity | -13.53 | -92.29 | 0.96 | -9.98 | 20.74 |
| Net inc/dec in cash and equivlnt | 102.36 | 1.63 | 0.56 | -1.90 | -0.57 |
| Cash and equivalnt begin of year | 3.35 | 1.12 | 0.55 | 2.45 | 3.13 |
| Cash and equivalnt end of year | 105.71 | 2.75 | 1.12 | 0.55 | 2.56 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis